Indications
For temporary relief of pain associated with arthritis.
Pleo Lari
FDA Label NDC 60681-1303
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Lari (NDC 60681-1303). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications, directions for use, dosage, ingredients, warning, tamper evident, principal display panel - 1 ml vial carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Directions For Use
Snap off top portion of sipping container. Insert glass sipping straw.
Dosage
1 SIP, twice weekly.
Ingredients
1 mL contains Laricifomes officinalis 5X, in a base of purified saline solution.
Warning
If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.
Tamper Evident
Do not use this product if the glass vial is broken or if imprinted security strip on carton is torn.
Principal Display Panel - 1 Ml Vial Carton
1303-2
Pleo™ Lari
PORTABLE SIPS 5X
Oral Homeopathic Medicine
INDICATIONS: For temporary relief of pain
associated with arthritis.
DIRECTIONS FOR USE: Snap off top
portion of sipping container. Insert glass
sipping straw.
DOSAGE: 1 SIP, twice weekly.
INGREDIENTS: 1 mL contains Laricifomes
officinalis 5X, in a base of purified saline
solution.
convenient, disposable
single dose containers
50 doses, each 1 mL
(.03 fl oz)
Rev. 12/97
Principal Display Panel (1 mL Vial Carton)
* Please review the disclaimer below.
